CEO increases shareholding in Meda

CEO increases shareholding in Meda

Meda's CEO, Anders Lönner, has bought 666 322 shares in connection with the new
share issue. His total shareholding now amounts to 4 664 254 shares, which is
equivalent to a market value of about 200 MSEK based on today's share price. 



For more information, please contact:

Anders Larnholt, Vice President Investor Relations, tel. +46 709 458 878


MEDA AB (publ) is a leading international specialty pharma company. The company
specialises in marketing and pharmaceutical development in late clinical stage.
Acquisitions and long-term partnerships are fundamental factors that drive the
company's strategy. Meda is represented by its own organisations in about 40
countries. Meda's products are sold in 120 countries worldwide. The Meda share
is listed under Large Cap on the OMX Nordic Stock Exchange. Find out more, visit
www.meda.se.